Skip to content

Rapid Learning for Lung Cancer

Rapid Learning in Practice: A Lung Cancer Survival Decision Support System in Routine Patient Care Data

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01949259
Enrollment
10000
Registered
2013-09-24
Start date
2013-09-30
Completion date
2014-08-31
Last updated
2016-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

Retrospective, Lung cancer

Brief summary

A retrospective, data mining project that re-uses routine patient care data for decision support systems.

Detailed description

By installing tools that extract clinical data from electronic health records and image data from the Picture Archiving and Communication System, decision support systems are built and validated that can predict survival and treatment toxicities of lung cancer patients treated with radiotherapy.

Interventions

None listed

Sponsors

Liverpool Cancer Therapy Centre
CollaboratorOTHER_GOV
Macarthur Cancer Therapy Centre, Liverpool
CollaboratorOTHER
Ingham Institute Hospital, Liverpool
CollaboratorUNKNOWN
NSW, Australia
CollaboratorUNKNOWN
Maastricht Radiation Oncology
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

\- Patients notes as suffering from lung cancer in at least one clinical data source.

Design outcomes

Primary

MeasureTime frameDescription
SurvivalFrom radiotherapy until deathRetrospective data will be collected from each included patient from start of radiotherapy until end of study or death (an expected average of 10 years).

Secondary

MeasureTime frameDescription
Local controlFrom start of treatment until death,Data will be collected from inclusion in the study until end of study of death (an expected average time frame of 10 years) concerning the local control of this tumour.
Distant metastasesFrom treatment until end of studyData concerning the possible occurence of distant metastases will be collected from each patient from inclusion until end of study or date of death (an expected average time frame of 10 years).
DyspneaFrom inclusion until end of studyFrom each included patient, dyspnea scores will be collected from start of treatment until end of study or date of death (an expected average time frame of 10 years).
DysphagiaFrom treatment until end of studyDysphagia scores will be collected from each participating patient from treatment until end of study or date of death (an average time frame of 10 years)

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026